Related references
Note: Only part of the references are listed.A novel EXT2 mutation in a consanguineous family with severe developmental delay, microcephaly, seizures, feeding difficulties, and osteopenia extends the phenotypic spectrum of autosomal recessive EXT2-related syndrome (AREXT2)
Lara El-Bazzal et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2019)
The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses
Maurizio Pacificl
MATRIX BIOLOGY (2018)
Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis
Athanasios D. Anastasilakis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition
Leelamma M. Panicker et al.
HUMAN MOLECULAR GENETICS (2018)
Heparan Sulfate Organizes Neuronal Synapses through Neurexin Partnerships
Peng Zhang et al.
CELL (2018)
Generation of osteoclasts from type 1 Gaucher patients and correlation with clinical and genetic features of disease
Matthew C. Reed et al.
GENE (2018)
Exploring genetic modifiers of Gaucher disease: The next horizon
Brad A. Davidson et al.
HUMAN MUTATION (2018)
Functional Characterization of a GGPPS Variant Identified in Atypical Femoral Fracture Patients and Delineation of the Role of GGPPS in Bone-Relevant Cell Types
Neus Roca-Ayats et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Common and rare variants of WNT16, DKK1 and SOST and their relationship with bone mineral density
Nuria Martinez-Gil et al.
SCIENTIFIC REPORTS (2018)
Reduced Activity of Geranylgeranyl Diphosphate Synthase Mutant Is Involved in Bisphosphonate-Induced Atypical Fractures
Michal Lisnyansky et al.
MOLECULAR PHARMACOLOGY (2018)
EPIDEMIOLOGY AND POSTOPERATIVE OUTCOMES OF ATYPICAL FEMORAL FRACTURES IN OLDER ADULTS: A SYSTEMATIC REVIEW
K. S. F. Khow et al.
JOURNAL OF NUTRITION HEALTH & AGING (2017)
Identification of a p.Arg708Gln variant in COL1A2 in atypical femoral fractures
Thomas Funck-Brentano et al.
JOINT BONE SPINE (2017)
GGPS1 Mutation and Atypical Femoral Fractures with Bisphosphonates
Neus Roca-Ayats et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase
C. Bondar et al.
BONE (2017)
What is the Proportion of Patients With Multiple Hereditary Exostoses Who Undergo Malignant Degeneration?
Cory M. Czajka et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2015)
Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses
Sali M. K. Farhan et al.
JOURNAL OF MEDICAL GENETICS (2015)
Exon array analysis reveals genetic heterogeneity in atypical femoral fractures. A pilot study
Isabel Perez-Nunez et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture
Hou-Feng Zheng et al.
NATURE (2015)
Somatic loss of an EXT2 gene mutation during malignant progression in a patient with hereditary multiple osteochondromas
Nicolo Musso et al.
CANCER GENETICS (2015)
EXTL2 and EXTL3 inhibition with siRNAs as a promising substrate reduction therapy for Sanfilippo C syndrome
Isaac Canals et al.
SCIENTIFIC REPORTS (2015)
Activity and High-Order Effective Connectivity Alterations in Sanfilippo C Patient-Specific Neuronal Networks
Isaac Canals et al.
STEM CELL REPORTS (2015)
Association between alendronate and atypical femur fractures: a meta-analysis
Lu Liu et al.
ENDOCRINE CONNECTIONS (2015)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease
Pramod K. Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A broad spectrum of genomic changes in latinamerican patients with EXT1/EXT2-CDG
M. A. Delgado et al.
SCIENTIFIC REPORTS (2014)
Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease
M. Reed et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease
Juan M. Mucci et al.
GENE (2013)
Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis
Lydia Gedmintas et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Mutations in the EXT1 and EXT2 genes in Spanish patients with multiple osteochondromas
P. Sarrion et al.
SCIENTIFIC REPORTS (2013)
Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-α
Juan M. Mucci et al.
GENE (2012)
A Novel Nonsense Mutation of the EXT1 Gene in an Argentinian Patient with Multiple Hereditary Exostoses
María Andrea Delgado et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2012)
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
Karol Estrada et al.
NATURE GENETICS (2012)
Bone Marrow Microenvironment in an In Vitro Model of Gaucher Disease: Consequences of Glucocerebrosidase Deficiency
Severine Lecourt et al.
STEM CELLS AND DEVELOPMENT (2012)
Markers of Bone Turnover in Gaucher Disease: Modeling the Evolution of Bone Disease
L. van Dussen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Diseases in a dish: modeling human genetic disorders using induced pluripotent cells
Gustavo Tiscornia et al.
NATURE MEDICINE (2011)
EXTra hit for mouse osteochondroma
Judith V. M. G. Bovee
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
Pramod K. Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
An overview on bone manifestations in Gaucher disease
Peter Mikosch et al.
WIENER MEDIZINISCHE WOCHENSCHRIFT (2010)
Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome
Philippe M. Campeau et al.
BLOOD (2009)
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Shu-Feng Zhou et al.
DRUG METABOLISM REVIEWS (2009)
Disease-specific induced pluripotent stem cells
In-Hyun Park et al.
CELL (2008)
Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases
Rey-Ting Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The crystal structure of human geranylgeranyl pyrophosphate synthase reveals a novel hexameric arrangement and inhibitory product binding
Kathryn L. Kavanagh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The molecular mechanism of nitrogen-containing bisphosphonates as anti osteoporosis drugs
Kathryn L. Kavanagh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Quality of life related to type 1 Gaucher disease:: Spanish experience
P Giraldo et al.
QUALITY OF LIFE RESEARCH (2005)
Gaucher disease: complexity in a simple disorder
E Sidransky
MOLECULAR GENETICS AND METABOLISM (2004)
The cell biology of lysosomal storage disorders
AH Futerman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Telomere-driven replicative senescence is a stress response
T von Zglinicki et al.
NATURE BIOTECHNOLOGY (2003)
Share Paper
